GO:0016829 lyase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016829 lyase activity describes enzymes that cleave C-C, C-O, C-N and other bonds without hydrolysis or oxidation, often generating a double bond or a new ring.
• Lyases are mechanistically distinct because they use two substrates in one reaction direction and a single substrate in the reverse direction, eliminating a small molecule to form a double bond or ring.
• Representative human lyases include cystathionine gamma-lyase (CTH), ACCS, TFAM, and glutamine transaminase K, each with distinct substrate specificities and physiological roles.
• Dysregulated lyase activity is linked to cancer, stroke, nonalcoholic steatohepatitis (NASH), and metabolic disorders through effects on sulfur amino acid metabolism, mitochondrial function, and microglial pyroptosis.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of lyase function in disease-relevant cell types.
• Lyase activity can be measured by enzyme-coupled assays, mass spectrometry, and activity stains, and its biological impact can be mapped by transcriptomics and proteomics.
Description
Lyases (EC 4) are a large class of enzymes defined by GO:0016829 that catalyze the cleavage of C-C, C-O, C-N and other bonds by means other than hydrolysis or oxidation, or conversely add a group to a double bond. Unlike hydrolases, lyases often use two substrates in one direction and one substrate in the reverse direction, eliminating a small molecule to generate a new double bond or ring. This mechanistic versatility places lyases at the center of diverse metabolic and signaling pathways, from sulfur amino acid catabolism to DNA repair and mitochondrial gene expression. For researchers, lyase activity matters because it connects enzyme chemistry to human disease. For example, cysteine S-conjugate beta-lyase activity of human ACCS and glutamine transaminase K contributes to xenobiotic metabolism and redox balance, while cystathionine gamma-lyase (CTH) regulates hydrogen sulfide production and d-amino acid handling. TFAM, best known as a mitochondrial transcription factor, also possesses 5'-deoxyribose phosphate lyase activity in vitro, linking lyase chemistry to mitochondrial DNA repair. Emerging evidence implicates lyase-related pathways in stroke, NASH, and cancer. CircFndc3b mediates exercise-induced neuroprotection by mitigating microglial/macrophage pyroptosis via the ENO1/KLF2 axis in stroke mice, and the hepatic Klf10-Fh1 axis promotes exercise-mediated amelioration of NASH in mice. These findings highlight lyase activity as a tractable target for mechanistic studies and therapeutic development.
lyase activity At A Glance
| GO ID | GO:0016829 |
|---|---|
| GO term | lyase activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Catalysis of bond cleavage (C-C, C-O, C-N and others) without hydrolysis or oxidation, often generating a double bond or ring. |
| Reaction direction | Two substrates in one direction; one substrate in the reverse direction, eliminating a small molecule. |
| Representative human enzymes | CTH, ACCS, TFAM, glutamine transaminase K. |
| Disease links | Cancer, stroke, NASH, metabolic disorders. |
| Research methods | Enzyme activity assays, activity stains, CRISPR models, transcriptomics. |
What Is GO:0016829?
GO:0016829 lyase activity is defined as catalysis of the cleavage of C-C, C-O, C-N and other bonds by means other than hydrolysis or oxidation, or conversely the addition of a group to a double bond. Lyases differ from other enzymes in that two substrates are involved in one reaction direction, but only one in the other direction. When acting on the single substrate, a molecule is eliminated and this generates either a new double bond or a new ring.
Why Is lyase activity Important in Cell Biology?
Lyase activity is important because it governs fundamental biochemical transformations that cannot be achieved by simple hydrolysis or oxidation, including desulfhydration, deamination, decarboxylation, and DNA repair chemistry. These reactions influence sulfur amino acid metabolism, mitochondrial function, xenobiotic detoxification, and redox signaling, and their dysregulation is associated with cancer, stroke, and NASH. Understanding lyase mechanism therefore provides both mechanistic insight and therapeutic opportunities.
• Lyases catalyze essential metabolic reactions such as cysteine S-conjugate beta-lyase activity, which contributes to xenobiotic metabolism and redox balance.
• CTH (cystathionine gamma-lyase) regulates hydrogen sulfide production and d-amino acid metabolism, impacting vascular and neurological function.
• TFAM 5'-deoxyribose phosphate lyase activity links mitochondrial transcription to DNA repair and mitochondrial genome stability.
• Lyase dysfunction is implicated in stroke through microglial/macrophage pyroptosis and the ENO1/KLF2 axis.
• Hepatic Klf10-Fh1 signaling, which intersects with lyase-related metabolism, promotes exercise-mediated amelioration of NASH in mice.
• Lyase activity is a target for drug discovery in cancer and metabolic disease because it controls key rate-limiting steps.
• Enzyme activity stains and coupled assays provide direct readouts of lyase function in cells and tissues.
• CRISPR-based models enable causal testing of lyase gene function in disease-relevant contexts.
Mechanism, Genes and Research Methods
Substrate recognition and binding
In simple terms: The enzyme first grabs its target molecule and positions it for chemical attack.
Lyases bind one or two substrates depending on reaction direction, using specific active-site residues to orient the scissile bond. For example, human ACCS recognizes cysteine S-conjugate sulfoxides, while CTH accommodates d-amino acids, illustrating distinct substrate specificities within the lyase family. Glutamine transaminase K and cysteine S-conjugate beta-lyase activity stains have been used to visualize substrate-dependent enzyme distribution in tissues.
Bond cleavage and elimination
In simple terms: The enzyme breaks a chemical bond and removes a small molecule, creating a double bond or ring.
The catalytic step involves cleavage of C-C, C-O, C-N or other bonds without water or oxygen, often through a carbanion or Schiff-base intermediate. In the reverse direction, a single substrate is converted into two products, or a group is added across a double bond. TFAM, for instance, catalyzes 5'-deoxyribose phosphate lyase activity in vitro, excising a sugar-phosphate residue during DNA repair.
Product release and ring formation
In simple terms: After cleavage, the enzyme releases the products, which may include a new ring structure.
Lyase reactions can generate new double bonds or rings, as seen in the elimination of small molecules from single substrates. Product release is often rate-limiting and can be regulated by substrate availability or post-translational modifications. Activity stains for cysteine S-conjugate beta-lyase demonstrate that product formation can be monitored directly in gels or tissue sections.
Structural determinants of lyase specificity
In simple terms: The shape of the enzyme's active site decides which molecules it can act on.
Domain swapping between AtACS7 and PpACL1 yields chimeric proteins with either ACS or C(beta)-S lyase single enzymatic activity, showing that domain architecture dictates lyase substrate specificity. Human ACCS and CTH have distinct active-site pockets that accommodate sulfoxides or d-amino acids, respectively. These structural features are critical for designing selective inhibitors or substrates.
Regulation by cellular context
In simple terms: The cell can turn lyase activity up or down depending on its needs.
Lyase activity is regulated at multiple levels, including gene expression, substrate availability, and post-translational modification. In stroke, circFndc3b mediates exercise-induced neuroprotection by mitigating microglial/macrophage pyroptosis via the ENO1/KLF2 axis, indirectly influencing lyase-related metabolic pathways. In NASH, the hepatic Klf10-Fh1 axis promotes exercise-mediated amelioration, linking lyase-associated metabolism to disease resolution.
Key Genes Involved in GO:0016829 lyase activity
The following genes encode enzymes or regulators with demonstrated lyase activity or direct relevance to lyase-dependent pathways in human cells and model organisms.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CTH | Cystathionine gamma-lyase; catalyzes desulfhydration and d-amino acid metabolism | Hydrogen sulfide production, vascular and neurological function |
| ACCS | Cysteine S-conjugate sulfoxide beta-lyase activity | Xenobiotic metabolism and redox balance |
| TFAM | 5'-deoxyribose phosphate lyase activity in vitro | Mitochondrial DNA repair and transcription |
| KYAT1 (glutamine transaminase K) | Cysteine S-conjugate beta-lyase activity | Detoxification and activity staining |
| AtACS7 | ACS-like lyase activity; domain-swapping model | Plant ethylene biosynthesis and enzyme engineering |
| PpACL1 | C(beta)-S lyase single enzymatic activity | Chimeric enzyme design and specificity studies |
| ENO1 | Enolase 1; linked to ENO1/KLF2 axis in stroke | Neuroprotection and microglial pyroptosis |
| KLF2 | Transcription factor downstream of ENO1 in stroke | Exercise-induced neuroprotection |
| KLF10 | Hepatic transcription factor in NASH | Exercise-mediated amelioration of NASH |
| FH1 | Fumarate hydratase 1; lyase in TCA cycle | NASH and metabolic regulation |
| CBS | Cystathionine beta-synthase; lyase-related sulfur metabolism | Transsulfuration and hydrogen sulfide |
| GOT1 | Glutamic-oxaloacetic transaminase 1; related to glutamine transaminase K | Amino acid metabolism |
| GOT2 | Glutamic-oxaloacetic transaminase 2; related to glutamine transaminase K | Mitochondrial amino acid metabolism |
| MPST | Mercaptopyruvate sulfurtransferase; sulfur metabolism | Hydrogen sulfide biology |
| NFS1 | Cysteine desulfurase; lyase-like sulfur transfer | Iron-sulfur cluster biogenesis |
| ACO2 | Aconitase 2; lyase in TCA cycle | Mitochondrial metabolism |
| OGDH | Oxoglutarate dehydrogenase; lyase-related complex | TCA cycle and NASH |
How Is lyase activity Regulated?
Lyase activity is regulated by substrate availability, gene expression, and post-translational modifications. For example, CTH activity toward d-amino acids is influenced by substrate concentration and cellular redox state. TFAM lyase activity is measured in vitro and may be modulated by DNA damage context. In stroke, circFndc3b mediates exercise-induced neuroprotection by mitigating microglial/macrophage pyroptosis via the ENO1/KLF2 axis, indirectly affecting lyase-related metabolic pathways. In NASH, the hepatic Klf10-Fh1 axis promotes exercise-mediated amelioration, linking lyase-associated metabolism to disease resolution.
lyase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CTH | Cancer, vascular disease, hydrogen sulfide metabolism | KO and overexpression in cancer cell lines |
| ACCS | Xenobiotic metabolism, redox balance | Point-mutation and KO in hepatocytes |
| TFAM | Mitochondrial DNA repair defects | Knock-in of lyase-dead TFAM in mitochondria |
| ENO1/KLF2 | Stroke, neuroinflammation | KO and overexpression in microglial cells |
| KLF10/FH1 | NASH, liver metabolism | Liver-specific KO and overexpression in mice |
Lyase activity in cancer and metabolic disease
Dysregulated lyase activity contributes to cancer and metabolic disease through altered sulfur amino acid metabolism and redox balance. CTH and ACCS modulate hydrogen sulfide and cysteine S-conjugate levels, which can influence tumor growth and chemoresistance. Targeting these enzymes is an active area of drug discovery.
Lyase activity in stroke and neuroprotection
CircFndc3b mediates exercise-induced neuroprotection by mitigating microglial/macrophage pyroptosis via the ENO1/KLF2 axis in stroke mice. This pathway intersects with lyase-dependent metabolic reactions, suggesting that lyase activity may influence neuroinflammatory outcomes.
Lyase activity in NASH and liver metabolism
The hepatic Klf10-Fh1 axis promotes exercise-mediated amelioration of NASH in mice. Fumarate hydratase 1 (FH1) is a lyase in the TCA cycle, and its regulation by KLF10 links lyase activity to hepatic metabolic homeostasis.
Lyase activity in mitochondrial DNA repair
TFAM has 5'-deoxyribose phosphate lyase activity in vitro, connecting lyase chemistry to mitochondrial DNA repair. Defects in this activity could contribute to mitochondrial genome instability and related disorders.
From lyase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CTH lyase activity alter hydrogen sulfide production? | CTH knockout cell line |
| Does ACCS point mutation affect cysteine S-conjugate sulfoxide metabolism? | ACCS point-mutation knock-in |
| Can TFAM lyase-dead mutant impair mitochondrial DNA repair? | TFAM knock-in with catalytic mutation |
| Does ENO1/KLF2 axis mediate exercise-induced neuroprotection? | ENO1 overexpression and KLF2 knockout in stroke mice |
| Does KLF10-FH1 axis regulate NASH amelioration? | Liver-specific KLF10 knockout and FH1 overexpression |
| Can domain-swapped lyases be engineered for desired specificity? | Chimeric AtACS7-PpACL1 knock-in |
How to Study the lyase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Coupled enzyme assay | Lyase catalytic rate | Kinetic characterization of ACCS |
| Activity stain | Cysteine S-conjugate beta-lyase activity | Tissue distribution of glutamine transaminase K |
| Mass spectrometry | Substrate and product levels | CTH d-amino acid metabolism |
| RNA-seq | Transcriptional changes | Stroke and NASH models |
| Proteomics | Protein expression and modifications | ENO1/KLF2 axis |
| CRISPR knockout | Loss-of-function phenotype | CTH knockout cells |
| CRISPR knock-in | Point-mutation effects | TFAM lyase-dead mutant |
| Domain swapping | Enzyme specificity | AtACS7-PpACL1 chimeras |
Enzyme activity assays
Lyase activity can be measured using coupled enzyme assays, mass spectrometry, or activity stains. Cysteine S-conjugate beta-lyase activity stains have been used to visualize enzyme distribution in tissues. ACCS beta-lyase activity toward cysteine S-conjugate sulfoxides can be quantified by substrate depletion or product formation.
Transcriptomics and proteomics
RNA-seq and proteomics can identify lyase gene expression changes in disease models. For example, the ENO1/KLF2 axis in stroke was dissected using transcriptomic profiling, and the Klf10-Fh1 axis in NASH was studied with hepatic gene expression analysis.
CRISPR-based functional genomics
CRISPR knockout, point-mutation, and knock-in models enable causal testing of lyase gene function. Domain-swapping between AtACS7 and PpACL1 produced chimeric proteins with single enzymatic activities, demonstrating the power of targeted editing.
Imaging and activity staining
Activity stains for cysteine S-conjugate beta-lyase allow spatial mapping of lyase activity in cells and tissues. Mitochondrial TFAM lyase activity can be assessed in vitro using DNA repair substrates.
How CRISPR Can Be Used to Study GO:0016829 lyase activity
Knockout
CRISPR knockout of lyase genes such as CTH or ACCS can reveal their contribution to sulfur amino acid metabolism and redox balance. Knockout models are essential for distinguishing catalytic activity from scaffolding functions.
Point Mutation
Point mutations in catalytic residues of TFAM or ACCS can selectively abolish lyase activity without affecting protein stability, enabling precise structure-function studies.
Knock-in
Knock-in of disease-associated or catalytically dead lyase variants, such as TFAM lyase-dead mutants, allows assessment of lyase activity in mitochondrial DNA repair. Domain-swapped chimeras can also be knocked in to study specificity.
Overexpression
Overexpression of lyase genes like ENO1 or KLF2 can test gain-of-function effects in stroke and neuroprotection models. Overexpression of FH1 or KLF10 can probe NASH amelioration.
How EDITGENE Supports lyase activity Research
Researchers studying lyase activity-related genes often need to determine whether a candidate gene is causally involved in a specific metabolic or disease phenotype. This requires precise genetic models that isolate catalytic activity from other protein functions.
Contact EDITGENE today to design your custom CRISPR model for lyase activity research.
Frequently Asked Questions About lyase activity
What is GO:0016829 lyase activity?
GO:0016829 lyase activity is a molecular function describing enzymes that cleave C-C, C-O, C-N and other bonds without hydrolysis or oxidation, often generating a double bond or ring.
What genes are involved in lyase activity?
Key human genes include CTH, ACCS, TFAM, and KYAT1 (glutamine transaminase K), each encoding enzymes with distinct lyase activities.
How is lyase activity different from hydrolase activity?
Lyases cleave bonds without water, whereas hydrolases use water to break bonds; lyases often use two substrates in one direction and one in the reverse.
What diseases are linked to lyase activity?
Lyase dysregulation is linked to cancer, stroke, NASH, and mitochondrial DNA repair defects.
How can I measure lyase activity in cells?
Coupled enzyme assays, activity stains, and mass spectrometry are commonly used to measure lyase activity.
What is the role of CTH in lyase activity?
CTH (cystathionine gamma-lyase) catalyzes desulfhydration and d-amino acid metabolism, influencing hydrogen sulfide production.
Does TFAM have lyase activity?
Yes, TFAM has 5'-deoxyribose phosphate lyase activity in vitro, linking it to mitochondrial DNA repair.
How are CRISPR models used to study lyase activity?
CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of lyase gene function in disease contexts.
What is cysteine S-conjugate beta-lyase activity?
It is a lyase activity that cleaves cysteine S-conjugates, important for xenobiotic metabolism and redox balance.
Can lyase activity be targeted therapeutically?
Yes, lyase enzymes such as CTH and ACCS are being explored as drug targets in cancer and metabolic disease.
Conclusion
GO:0016829 lyase activity defines a fundamental class of enzymes that cleave chemical bonds without hydrolysis or oxidation, generating double bonds or rings. Their roles in sulfur amino acid metabolism, mitochondrial DNA repair, and disease pathways make them important research targets. CRISPR-based models, combined with activity assays and omics profiling, provide powerful tools to dissect lyase function and translate these insights into therapeutic strategies.
References
- 1. Gao J et al.. 2025. Cysteine S-conjugate sulfoxide β-lyase activity for human ACCS.. FEBS J 292(9):2272-2286 PMID: 39876065
- 2. Zhao W et al.. 2024. Mitochondrial transcription factor A (TFAM) has 5'-deoxyribose phosphate lyase activity in vitro.. DNA Repair (Amst) 137:103666 PMID: 38492429
- 3. Zhao Y et al.. 2025. CircFndc3b Mediates Exercise-Induced Neuroprotection by Mitigating Microglial/Macrophage Pyroptosis via the ENO1/KLF2 Axis in Stroke Mice.. Adv Sci (Weinh) 12(1):e2403818 PMID: 39467260
- 4. Luo HY et al.. 2024. Hepatic Klf10-Fh1 axis promotes exercise-mediated amelioration of NASH in mice.. Metabolism 155:155916 PMID: 38615945
- 6. Miyamoto T et al.. 2022. Characterization of human cystathionine γ-lyase enzyme activities toward d-amino acids.. Biosci Biotechnol Biochem 86(11):1536-1542 PMID: 36085174
- 7. Xu C et al.. 2023. Domain Swapping between AtACS7 and PpACL1 Results in Chimeric ACS-like Proteins with ACS or C(β)-S Lyase Single Enzymatic Activity.. Int J Mol Sci 24(3) PMID: 36769285
- 8. Abraham DG et al.. 1991. Glutamine transaminase K and cysteine S-conjugate beta-lyase activity stains.. Anal Biochem 197(2):421-7 PMID: 1723851
